This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Genot, S.
Right arrow Articles by Ranque, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Genot, S.
Right arrow Articles by Ranque, S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2007, p. 3138-3140, Vol. 45, No. 9
0095-1137/07/$08.00+0     doi:10.1128/JCM.00021-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

CASE REPORT

Severe Toxoplasma gondii I/III Recombinant-Genotype Encephalitis in a Human Immunodeficiency Virus Patient{triangledown}

Séverine Genot,1 Jacqueline Franck,2,3 Jean-Marie Forel,4 Stanislas Rebaudet,1 Daniel Ajzenberg,3,5 Andre Maues de Paula,6 Marie-Laure Dardé,3,5 Andreas Stein,1 and Stéphane Ranque2*

Service des Maladies Infectieuses, Hôpital de la Conception,1 Laboratoire de Parasitologie-Mycologie,2 Laboratoire d’Anatomopathologie,6 Hôpital Timone, and Département d’Anesthésie-Réanimation, Hôpital Sainte Marguerite,4 Marseille, and Faculté de Médecine, EA3174,5 Centre National Référence de la Toxoplasmose, Limoges, France3

Received 4 January 2007/ Returned for modification 12 March 2007/ Accepted 2 July 2007

The reactivation of an uncommon type I/III recombinant-genotype Toxoplasma gondii strain resulted in unusually severe encephalitis and chorioretinitis associated with a cerebral salt wasting syndrome in an African human immunodeficiency virus patient. This observation suggests an influence of the parasite genotype on disease expression in immunocompromised patients.


* Corresponding author. Mailing address: Laboratoire de Parasitologie-Mycologie, AP-HM Timone, F-13385 Marseille Cedex 5, France. Phone: 33 491.38.60.90. Fax: 33 491.38.49.58. E-mail: stephane.ranque{at}ap-hm.fr

{triangledown} Published ahead of print on 18 July 2007.


Journal of Clinical Microbiology, September 2007, p. 3138-3140, Vol. 45, No. 9
0095-1137/07/$08.00+0     doi:10.1128/JCM.00021-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Messaritakis, I., Detsika, M., Koliou, M., Sifakis, S., Antoniou, M. (2008). Prevalent Genotypes of Toxoplasma gondii in Pregnant Women and Patients from Crete and Cyprus. Am J Trop Med Hyg 79: 205-209 [Abstract] [Full Text]